Thomas Weisel Starts Obagi Medical (OMPI) at Market Weight
Thomas Weisel starts Obagi Medical (Nasdaq: OMPI) at Market Weight with a $7 price target.
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
